UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$602M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$296M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$256M |
| 4 |
Enterprise Products Partners
EPD
|
+$252M |
| 5 |
Charter Communications
CHTR
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.22B |
| 2 |
CVS Health
CVS
|
+$465M |
| 3 |
Mondelez International
MDLZ
|
+$382M |
| 4 |
SHPG
Shire pic
SHPG
|
+$221M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.78% |
| 2 | Technology | 7.19% |
| 3 | Healthcare | 5.6% |
| 4 | Industrials | 5.06% |
| 5 | Consumer Discretionary | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7151
Eltek
ELTK
$56.9M
| $7K | ﹤0.01% |
+1,717
| New | +$6.04K |
|
|
EVOK
7152
DELISTED
Evoke Pharma
EVOK
| $7K | ﹤0.01% |
23
+7
| +44% | +$2.9K |
|
7153
Glaukos
GKOS
$9.83B
| $7K | ﹤0.01% |
286
-1,171
| -80% | -$34.8K |
|
7154
Galmed Pharmaceuticals
GLMD
$5.13M
| $7K | ﹤0.01% |
+4
| New | +$5.91K |
|
7155
Lee Enterprises
LEE
$172M
| $7K | ﹤0.01% |
316
-493
| -61% | -$11.6K |
|
7156
Centrus Energy
LEU
$3.48B
| $7K | ﹤0.01% |
1,743
+983
| +129% | +$3.97K |
|
|
LND
7157
BrasilAgro
LND
$374M
| $7K | ﹤0.01% |
2,107
+1,567
| +290% | +$5.96K |
|
7158
PUT
iShares MSCI China ETF
MCHI
$6.32B
| $7K | ﹤0.01% |
100
| – | – |
|
7159
MediWound
MDWD
$181M
| $7K | ﹤0.01% |
216
+184
| +575% | +$6.19K |
|
7160
Medallion Financial
MFIN
$229M
| $7K | ﹤0.01% |
2,067
-3,331
| -62% | -$9.09K |
|
7161
Microvision
MVIS
$6.21M
| $7K | ﹤0.01% |
3,852
+920
| +31% | +$1.77K |
|
7162
Optical Cable Corp
OCC
$131M
| $7K | ﹤0.01% |
3,008
-1,403
| -32% | -$3.46K |
|
7163
Ocugen
OCGN
$416M
| $7K | ﹤0.01% |
+57
| New | +$6.97K |
|
7164
Pro-Dex
PDEX
$187M
| $7K | ﹤0.01% |
996
-2,348
| -70% | -$17K |
|
7165
The 3D Printing ETF
PRNT
$59.5M
| $7K | ﹤0.01% |
+291
| New | +$7.43K |
|
7166
Pyxis Tankers
PXS
$48.7M
| $7K | ﹤0.01% |
+517
| New | +$5.52K |
|
7167
RBB Bancorp
RBB
$448M
| $7K | ﹤0.01% |
268
-483
| -64% | -$12K |
|
7168
Rimini Street
RMNI
$449M
| $7K | ﹤0.01% |
+872
| New | +$7.37K |
|
7169
PUT
Global X Silver Miners ETF NEW
SIL
$3.98B
| $7K | ﹤0.01% |
200
-4,800
| -96% | -$154K |
|
|
DCOY
7170
Decoy Therapeutics
DCOY
$2.19M
| – | – |
0
| – | – |
|
7171
SELLAS Life Sciences
SLS
$1.97B
| $7K | ﹤0.01% |
17
+11
| +183% | +$5.32K |
|
7172
Spyre Therapeutics
SYRE
$8.54B
| $7K | ﹤0.01% |
53
-25
| -32% | -$3.06K |
|
7173
US Gold Corp
USAU
$214M
| $7K | ﹤0.01% |
420
+210
| +100% | +$3.06K |
|
7174
PUT
Vanguard Total World Stock ETF
VT
$77.1B
| $7K | ﹤0.01% |
100
| – | – |
|
7175
Xenetic Biosciences
XBIO
$5.82M
| $7K | ﹤0.01% |
31
+15
| +94% | +$4.25K |
|
Similar funds
UBS Group's Q4 2017 Portfolio in Review
As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.
- UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
- UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
- UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
- UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
- UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
- UBS Group opened 751 new positions and closed 634 in Q4 2017.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.
Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.